From a presser:
Erie, Pennsylvania - The Kanzius Cancer Research Foundation announced today that Steven Curley M.D., primary investigator of the Kanzius Non-invasive Radio Wave Cancer Treatment at The University of Texas MD Anderson Cancer Center has been awarded a $2.1 million grant from the National Cancer Institute (NCI). This grant, to be paid over the next five years, will be used for continuing research on the Kanzius Treatment which seeks to kill human cancer cells treated with gold nanoparticles without damaging healthy cells.
“This is incredibly exciting and encouraging news for the Kanzius Foundation,” said Mark A. Neidig Sr., Executive Director of the Erie, Pennsylvania based Kanzius Cancer Research Foundation. “An NCI grant positions our research work with a stronger base; one which makes a very loud statement regarding the credibility and validity of both our preliminary findings and future studies.”
The work of the Kanzius Cancer Research Foundation is far from complete. The added funding to Dr. Curley’s research is but one aspect of funding needed to advance the multiple research venues utilizing the Kanzius technology and to secure FDA approval.
“The NCI grant was sorely needed and advances our work with vigor,” said Neidig. “However, the total pre-human clinical trial cost is upwards to $12 million so our work continues.”
To read more about the NCI grant, please visit www.KanziusCancerResearch.org now.
On the home front against cancer, I attended a Team In Training meeting last night, having agreed to be a Coach. I met two people impacted by blood cancer. One young lady's 34-year-old brother-in-law is a Hodgkins' Lymphoma survivor (18 months), while another man recently lost his grandmother three days after she was diagnosed with AML.
I will be coaching activist runners like these as we train for the Country Music Half Marathon in April.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment